Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6361 to 6375 of 9045 results

  1. How the faecal immunochemical test is changing bowel cancer referrals and what it tells us about the power of NICE guidance

    Learn how NICE's healthtech guidance is accelerating NHS adoption of a simple bowel cancer test, preventing 140,000 unnecessary urgent referrals a year while keeping cancer detection rates stable.

  2. First disease-modifying therapy for NHS use to delay the onset of type 1 diabetes recommended

    A first-of-its-kind therapy that can delay the onset of type 1 diabetes for up to 3 years is to be made available on the NHS.

  3. From £1 to £180: how NICE guidance helped us make smarter slide sheet choices

    Learn how our evidence-based guidance helped a London NHS trust standardise procurement and generate operational efficiencies.

  4. Our evidence standards framework for digital care technologies

    NICE has been commissioned by the Department of Health and Social Care and NHS England to adapt the evidence standards framework for digital health technologies to support evidence-based decision making for digital care technologies used in adult social care.

  5. New machines that keep donor livers alive outside the body could help hundreds waiting for a life-saving transplant

    A consultation has begun on draft guidance recommending 4 specialist liver preservation machines for routine NHS use, which could help more of the 600 people in England waiting for a life-saving transplant.

  6. Over 1,500 people set to benefit from first immunotherapy for aggressive stomach cancer

    The targeted treatment helps people live longer and can help prevent the disease from returning.

  7. Routine NHS access to spinal muscular atrophy treatments offers new hope for patients and families

    People living with spinal muscular atrophy (SMA) in England are set to gain routine access to two potentially life-changing treatments, following our publication of final draft guidance today.

  8. Improving outcomes in haemato-oncology cancer (CSG3)

    This guidance has been updated and replaced by NICE guideline NG47.

  9. Improving outcomes in colorectal cancer (CSG5)

    This guidance has been updated and replaced by NICE guideline NG151.

  10. Magtrace and Sentimag system for locating sentinel lymph nodes for breast cancer (MTG72)

    We have moved Medical technologies guidance 72 to become HealthTech guidance 642. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  11. GreenLight XPS for treating benign prostatic hyperplasia (MTG74)

    We have moved Medical technologies guidance 74 to become HealthTech guidance 650. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  12. Memokath 051 Ureter stent for ureteric obstruction (MTG75)

    We have moved Medical technologies guidance 75 to become HealthTech guidance 651. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  13. Kurin Lock for blood culture collection (MTG77)

    We have moved Medical technologies guidance 77 to become HealthTech guidance 715. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  14. MiraQ for assessing graft flow during coronary artery bypass graft surgery (MTG8)

    We have moved medical technologies guidance 8 to become HealthTech guidance 275. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  15. GaitSmart rehabilitation exercise programme for gait and mobility issues (MTG78)

    We have moved Medical technologies guidance 78 to become HealthTech guidance 716. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.